Needham & Company Downgrades Argos Therapeutics (ARGS) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
JMP Securities Downgrades Argos Therapeutics (ARGS) to Market Perform
February 22, 2017 1:54 PM ESTJMP Securities downgraded Argos Therapeutics (NASDAQ: ARGS) from Market Outperform to Market Perform (from $12.00).
For an analyst ratings summary and ratings history on Argos Therapeutics click here. For more ratings news on Argos Therapeutics click here.
Shares of Argos Therapeutics closed at $4.40 yesterday.
... MoreFBR Capital Downgrades Argos Therapeutics (ARGS) to Market Perform
February 22, 2017 1:53 PM ESTFBR Capital downgraded Argos Therapeutics (NASDAQ: ARGS) from Outperform to Market Perform with a price target of $2.00 (from $13.00).
For an analyst ratings summary and ratings history on Argos Therapeutics click here. For more ratings news on Argos Therapeutics click here.
Shares of Argos Therapeutics closed at $4.40 yesterday.
... MoreStifel Downgrades Argos Therapeutics (ARGS) to Hold
February 22, 2017 11:00 AM ESTStifel downgraded Argos Therapeutics (NASDAQ: ARGS) from Buy to Hold with a price target of $1.40.
For an analyst ratings summary and ratings history on Argos Therapeutics click here. For more ratings news on Argos Therapeutics click here.
Shares of Argos Therapeutics closed at $4.40 yesterday.
... More